Flavoxate Hydrochloride Tablets, 100 mg Film-Coated

Manufacturer
TAGI Pharma, Inc.
Effective date
2019-08-27
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 00:14:00

Label at a glance#

ProductFlavoxate Hydrochloride
Active ingredientFlavoxate hydrochloride
Label structure13 sections

Indications and uses

Flavoxate hydrochloride tablets are indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/ urethrotrigonitis. Flavoxate hydrochloride tablets are not indicated for definitive treatment, but are compatible with drugs used for the treatment of urinary tract infections.

Dosage and administration

One or two 100 mg tablets 3 or 4 times a day. With improvement of symptoms, the dose may be reduced. This drug cannot be recommended for infants and children under 12 years of age because safety and efficacy have not been demonstrated in this age group.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

DESCRIPTION

DESCRIPTION SECTION

Flavoxate hydrochloride tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.

Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride. The empirical formula of flavoxate hydrochloride is C24H25NO4∙HCl. The molecular weight is 427.94. The structural formula appears below.

Chemical Structure
Chemical Structure

Each tablet for oral administration contains 100 mg flavoxate hydrochloride. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, corn starch, dibasic calcium phosphate dihydrate, magnesium stearate, hypromellose, polydextrose, polyethylene glycol, titanium dioxide and triacetin.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Flavoxate hydrochloride counteracts smooth muscle spasm of the urinary tract and exerts its effect directly on the muscle.

In a single study of 11 normal male subjects, the time to onset of action was 55 minutes. The peak effect was observed at 112 minutes. 57% of the flavoxate hydrochloride was excreted in the urine within 24 hours.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Flavoxate hydrochloride tablets are indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/ urethrotrigonitis. Flavoxate hydrochloride tablets are not indicated for definitive treatment, but are compatible with drugs used for the treatment of urinary tract infections.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Flavoxate hydrochloride is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.

WARNINGS

WARNINGS SECTION

Flavoxate hydrochloride should be given cautiously in patients with suspected glaucoma.

PRECAUTIONS

PRECAUTIONS SECTION

Information for Patients

INFORMATION FOR PATIENTS SECTION

Patients should be informed that if drowsiness and blurred vision occur, they should not operate a motor vehicle or machinery or participate in activities where alertness is required.

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Mutagenicity studies and long-term studies in animals to determine the carcinogenic potential of flavoxate hydrochloride have not been performed.

Pregnancy

PREGNANCY SECTION

Teratogenic Effects

TERATOGENIC EFFECTS SECTION

Pregnancy Category B

SPL UNCLASSIFIED SECTION

Reproduction studies have been performed in rats and rabbits at doses up to 34 times the human dose and revealed no evidence of impaired fertility or harm to the fetus due to flavoxate hydrochloride. There are, however, no well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mother

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when flavoxate hydrochloride is administered to a nursing woman.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in children below the age of 12 years have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency.

Gastrointestinal: Nausea, vomiting, dry mouth.

CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness.

Hematologic: Leukopenia (one case which was reversible upon discontinuation of the drug).

Cardiovascular: Tachycardia and palpitation.

Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia.

Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation.

Renal: Dysuria.

OVERDOSAGE

OVERDOSAGE SECTION

The oral LD50 for flavoxate hydrochloride in rats is 4273 mg/kg. The oral LD50 for flavoxate hydrochloride in mice is 1837 mg/kg.

It is not known whether flavoxate hydrochloride is dialyzable.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Adults and children over 12 years of age

SPL UNCLASSIFIED SECTION

One or two 100 mg tablets 3 or 4 times a day. With improvement of symptoms, the dose may be reduced. This drug cannot be recommended for infants and children under 12 years of age because safety and efficacy have not been demonstrated in this age group.

HOW SUPPLIED

HOW SUPPLIED SECTION

Flavoxate hydrochloride 100 mg tablets are available as white, round biconvex, film-coated tablets, debossed "Ɛ58" on one side and plain on the other side, and are available in bottles of 100 and 1000.

STORAGE AND HANDLING SECTION

Store at 20° - 25°C (68° - 77°F) [see USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container.

SPL UNCLASSIFIED SECTION

Distributed by:
TAGI Pharma
South Beloit, IL 61080

Manufactured by
Epic Pharma, LLC
Laurelton, NY 11413

Made in USA

Revised 02/15
MF058REV02/15
OE1252

PRINCIPAL DISPLAY PANEL - 100 mg Tablets Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 51224-154-50

Flavoxate
Hydrochloride
Tablets

100 mg

Rx Only

100 Film-Coated
Tablets

tagiPHARMA

PRINCIPAL DISPLAY PANEL - 100 mg Tablets Bottel Label
PRINCIPAL DISPLAY PANEL - 100 mg Tablets Bottel Label

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51224-154-50EA - Each51224-154da0ca5dc-9e37-4122-8965-4d96d4260b7712012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Flavoxate hydrochlorideACTIVE INGREDIENT9C05J6089W1
FlavoxateACTIVE MOIETY3E74Y80MEY1
dibasic calcium phosphate dihydrateINACTIVE INGREDIENTO7TSZ97GEP1
hypromellosesINACTIVE INGREDIENT3NXW29V3WO1
magnesium stearateINACTIVE INGREDIENT70097M6I301
polydextroseINACTIVE INGREDIENTVH2XOU12IE1
silicon dioxideINACTIVE INGREDIENTETJ7Z6XBU41
starch, cornINACTIVE INGREDIENTO8232NY3SJ1
titanium dioxideINACTIVE INGREDIENT15FIX9V2JP1
triacetinINACTIVE INGREDIENTXHX3C3X6731

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51224-15451224-154-50, 51224-154-70

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 204 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPOINTMENT / TOPICAL5 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
dibasic calcium phosphate dihydrateDIBASIC CALCIUM PHOSPHATE DIHYDRATEO7TSZ97GEPPASTE, DENTIFRICE / DENTAL51 %w/wExact identifier — unii candidate
10 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJSUSPENSION / ORAL900 mgExact identifier — unii candidate
22 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOTABLET, CHEWABLE / ORAL11.8 mgExact identifier — unii candidate
27 equally ranked IID candidates
triacetinTRIACETINXHX3C3X673TABLET, FILM COATED / ORAL15.12 mgExact identifier — unii candidate
14 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4TABLET, DELAYED RELEASE PARTICLES / ORAL170 mgExact identifier — unii candidate
49 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJCAPSULE, COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
22 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING / ORAL187 mgExact identifier — unii candidate
39 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOGEL / RECTAL348 mgExact identifier — unii candidate
27 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJCAPSULE / ORAL5785 mgExact identifier — unii candidate
22 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJTABLET / SUBLINGUAL409 mgExact identifier — unii candidate
22 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOTABLET, DELAYED RELEASE / ORAL79 mgExact identifier — unii candidate
27 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, DELAYED RELEASE / ORAL66 mgExact identifier — unii candidate
40 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPSOAP / TOPICAL1 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL42 mgExact identifier — unii candidate
40 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJTABLET / ORAL1116 mgExact identifier — unii candidate
22 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED / ORAL17 mgExact identifier — unii candidate
40 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30TABLET, DELAYED RELEASE / ORAL144 mgExact identifier — unii candidate
39 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING / ORAL6 mgExact identifier — unii candidate
40 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOTABLET / ORAL1127 mgExact identifier — unii candidate
27 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
40 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJDROPS / ORALNAExact identifier — unii candidate
22 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4PELLET / ORAL34 mgExact identifier — unii candidate
49 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJTABLET, FILM COATED / ORAL2000 mgExact identifier — unii candidate
22 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30CAPSULE, EXTENDED RELEASE / ORAL117 mgExact identifier — unii candidate
39 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE / ORAL254 mgExact identifier — unii candidate
49 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30IMPLANT / INTRAVITREALNAExact identifier — unii candidate
39 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPFILM / BUCCAL3 mgExact identifier — unii candidate
40 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPGRANULE, FOR SUSPENSION / ORAL143 mgExact identifier — unii candidate
40 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPSUSPENSION / ORAL113 mgExact identifier — unii candidate
40 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOTABLET, EXTENDED RELEASE / ORAL1472 mgExact identifier — unii candidate
27 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOINSERT / VAGINAL54.21 mgExact identifier — unii candidate
27 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJPASTILLE / ORALNAExact identifier — unii candidate
22 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE / ORAL72 mgExact identifier — unii candidate
40 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30POWDER / ORAL25 mgExact identifier — unii candidate
39 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOJELLY / TOPICALNAExact identifier — unii candidate
27 equally ranked IID candidates
triacetinTRIACETINXHX3C3X673CAPSULE / ORAL13 mgExact identifier — unii candidate
14 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, COATED / ORAL49 mgExact identifier — unii candidate
40 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOSYSTEM / TOPICAL54 mgExact identifier — unii candidate
27 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4CAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
49 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4POWDER / ORAL602 mgExact identifier — unii candidate
49 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4DROPS / ORALNAExact identifier — unii candidate
49 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE / ORAL55 mgExact identifier — unii candidate
40 equally ranked IID candidates
dibasic calcium phosphate dihydrateDIBASIC CALCIUM PHOSPHATE DIHYDRATEO7TSZ97GEPTABLET / ORAL2442 mgExact identifier — unii candidate
10 equally ranked IID candidates
polydextrosePOLYDEXTROSEVH2XOU12IETABLET, EXTENDED RELEASE / ORAL22 mgExact identifier — unii candidate
3 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED PELLETS / ORAL4.4 mgExact identifier — unii candidate
40 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4POWDER, FOR SUSPENSION / ORAL2553 mgExact identifier — unii candidate
49 equally ranked IID candidates
silicon dioxideSILICON DIOXIDEETJ7Z6XBU4CAPSULE, LIQUID FILLED / ORAL106 mgExact identifier — unii candidate
49 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPPASTE, DENTIFRICE / DENTAL0.4 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPFILM, SOLUBLE / BUCCAL11 mgExact identifier — unii candidate
40 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
27 equally ranked IID candidates
starch, cornSTARCH, CORNO8232NY3SJSUSPENSION, EXTENDED RELEASE / ORAL113 mgExact identifier — unii candidate
22 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30CAPSULE, DELAYED RELEASE / ORAL1060 mgExact identifier — unii candidate
39 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPLOTION / TOPICALNAExact identifier — unii candidate
40 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOTABLET, COATED / ORAL58 mgExact identifier — unii candidate
27 equally ranked IID candidates
hypromellosesHYPROMELLOSE3NXW29V3WOCAPSULE, COATED PELLETS / ORAL3.32 mgExact identifier — unii candidate
27 equally ranked IID candidates
magnesium stearateMAGNESIUM STEARATE70097M6I30PELLET / ORAL24 mgExact identifier — unii candidate
39 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPDROPS / ORALNAExact identifier — unii candidate
40 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A076835-001FLAVOXATE HYDROCHLORIDEFLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A076835-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30d4dbc9d85df4…
2026-10-15 13:18:302026-09A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30c2088c7a36db…
2026-09-14 22:38:342026-08A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-3084e616aacf4f…
2026-08-18 06:07:402026-07A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-304b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-3074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-3087673890dc5c…
2021-03-12 10:30 UTC2021-03A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-305aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-303f01610625f2…
2019-09-15 20:21 UTC2019-09A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30b00525d2431f…
2019-07-19 19:46 UTC2019-07A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-306a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-301c564ffb4f44…
2023-12-20 04:57 UTC2023-12A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-309b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-303f0d92c62455…
2023-05-13 08:27 UTC2023-05A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-30053a50430f4f…
2023-01-26 05:58 UTC2023-01A076835-001FLAVOXATE HYDROCHLORIDE100MGTABLET / ORALAB2005-11-303bdfa0b2c4d7…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A076835-001AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A076835-001AB1c2088c7a36db…
2026-09-14 22:38:342026-08A076835-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A076835-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076835-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076835-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A076835-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076835-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076835-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076835-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076835-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A076835-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A076835-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A076835-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076835-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076835-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076835-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A076835-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076835-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A076835-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A076835-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A076835-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A076835-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A076835-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076835-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A076835-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A076835-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A076835-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A076835-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A076835-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A076835-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A076835-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A076835-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A076835-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A076835-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A076835-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A076835-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A076835-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A076835-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A076835-001AB13bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f3fe09d9-1537-40f4-aaab-627a7e05e1495cc7ad48-0918-444d-a97e-64c43852f3a62019-08-27Warnings, Adverse reactionsExact identifier
spl id: f3fe09d9-1537-40f4-aaab-627a7e05e149
spl set id: 5cc7ad48-0918-444d-a97e-64c43852f3a6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.